Tremor-dominant clinical phenotype is associated with low risk of levodopa-induced dyskinesia in Parkinson's Disease

被引：0
|
作者：
Santos-Lobato, B.
Capelari, M.
Novaretti, N.
Vieira, A.
Borges, V.
Ferraz, H.
Hata, I.
Zabetian, C.
Tumas, V.
机构：
来源：
MOVEMENT DISORDERS | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
5
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
    Soares, Nayron Medeiros
    Pereira, Gabriela Magalhaes
    Dutra, Ana Carolina Leonardi
    Artigas, Nathalie Ribeiro
    Krimberg, Julia Schneider
    Monticelli, Bruno Elkfury
    Schumacher-Schuh, Artur Francisco
    de Almeida, Rosa Maria Martins
    Rieder, Carlos Roberto de Mello
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2023, 81 (01) : 40 - 46
  • [32] Cortico-cortical connectivity is normalised by levodopa in tremor-dominant Parkinson's disease
    Rurak, B. K.
    Rodrigues, J. P.
    Power, B. D.
    Drummond, P. D.
    Vallence, A. M.
    MOVEMENT DISORDERS, 2022, 37 : S430 - S431
  • [33] Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment
    Thanvi, Bhomraj
    Lo, Nelson
    Robinson, Tom
    POSTGRADUATE MEDICAL JOURNAL, 2007, 83 (980) : 384 - 388
  • [34] Polymorphisms of glutamatergic system genes are associated with levodopa-induced dyskinesia in Parkinson's disease
    Mironova, I.
    Latypova, A.
    Zhukova, I.
    Izhboldina, O.
    Kolupaeva, E.
    Zhukova, N.
    Ivanova, S.
    MOVEMENT DISORDERS, 2018, 33 : S624 - S624
  • [35] Coffee Consumption and Risk of Levodopa-Induced Dyskinesia in Parkinson's Disease: The FRAGAMP Study
    Nicoletti, Alessandra
    Zappia, Mario
    MOVEMENT DISORDERS, 2015, 30 (13) : 1854 - 1856
  • [36] A Web Resource for Levodopa-Induced Dyskinesia Genetics in Parkinson's Disease
    Blankenburg, Hagen
    Falla, Marika
    Schwienbacher, Christine
    Fabbrini, Giovanni
    Berardelli, Alfredo
    Pramstaller, Peter P.
    Domingues, Francisco S.
    NEUROINFORMATICS, 2017, 15 (03) : 297 - 300
  • [37] Effect of Safinamide on Levodopa-Induced Dyskinesia in Patients with Parkinson's Disease
    Bhatt, Mohit
    Chirileanu, Dana
    Meshram, Chandrashekhar
    Stanzione, Paolo
    Forrest, Emma C.
    NEUROLOGY, 2010, 74 (09) : A319 - A319
  • [38] Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatment
    Theresa A. Zesiewicz
    Kelly L. Sullivan
    Robert A. Hauser
    Current Neurology and Neuroscience Reports, 2007, 7 : 302 - 310
  • [39] White matter alterations in Parkinson's disease with levodopa-induced dyskinesia
    Ogawa, Takashi
    Hatano, Taku
    Kamagata, Koji
    Andica, Christina
    Takeshige-Amano, Haruka
    Uchida, Wataru
    Saito, Yuya
    Shimo, Yasushi
    Oyama, Genko
    Umemura, Atsushi
    Iwamuro, Hirokazu
    Ito, Masanobu
    Hori, Masaaki
    Aoki, Shigeki
    Hattori, Nobutaka
    PARKINSONISM & RELATED DISORDERS, 2021, 90 : 8 - 14
  • [40] Pridopidine for the treatment of Levodopa-induced Dyskinesia in patients with Parkinson's disease
    Geva, M.
    McGarry, A.
    Cohen, Y.
    Johnston, T.
    de Somer, M.
    Kieburtz, K.
    Hayden, M.
    Brotchie, J.
    Olanow, C.
    MOVEMENT DISORDERS, 2020, 35 : S396 - S396
12345